Azur's Bid For Contract Clarity Tossed In $35M FazaClo Feud
A California judge on Monday tossed Azur Pharma Ltd.'s counterclaims in a $35 million suit by the inventor of FazaClo alleging Azur manipulated sales of the antipsychotic drug to shirk milestone...To view the full article, register now.
Already a subscriber? Click here to view full article